It has been reported that MLH1 polymorphisms correlate with the pathogenesis of colorectal cancer, lung cancer, breast cancer, prostate cancer, head and neck squamous cell carcinoma, and oral squamous cell carcinoma29–36. This evidence concerns the gene MLH1 and colorectal cancer.